SEC 13F Intelligence

Handelsbanken Fonder AB / BIIB

Handelsbanken Fonder AB’s Biogen Inc Position

Does Handelsbanken Fonder AB own Biogen Inc (BIIB)? Yes — 82.7K shares worth $15M (+0.05% of its 13F portfolio) as of Q1 2026, down from 84.2K shares the prior filed quarter.

Position Value
$15M
Q1 2026
Shares
82.7K
% of Portfolio
+0.05%
Quarters Held
26
currently held

Position History BIIB

Reported value by quarter
Q4 ’19: $13MQ4 ’19Q1 ’20: $12MQ2 ’20: $35MQ3 ’20: $18MQ4 ’20: $15MQ4 ’20Q1 ’21: $24MQ2 ’21: $33MQ3 ’21: $25MQ4 ’21: $16MQ4 ’21Q1 ’22: $9MQ2 ’22: $16MQ3 ’22: $21MQ4 ’22: $18MQ4 ’22Q1 ’23: $19MQ2 ’23: $21MQ3 ’23: $19MQ4 ’23: $15MQ4 ’23Q1 ’24: $14MQ2 ’24: $16MQ3 ’24: $13MQ4 ’24: $13MQ4 ’24Q1 ’25: $11MQ2 ’25: $12MQ3 ’25: $14MQ4 ’25: $15MQ4 ’25Q1 ’26: $15Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202682.7K$15M+0.05%
Q4 202584.2K$15M+0.04%
Q3 202599.3K$14M+0.04%
Q2 202597.6K$12M+0.04%
Q1 202580.3K$11M+0.05%
Q4 202481.9K$13M+0.05%
Q3 202468.5K$13M+0.05%
Q2 202467.2K$16M+0.07%
Q1 202464.1K$14M+0.06%
Q4 202357.5K$15M+0.07%
Q3 202375.8K$19M+0.11%
Q2 202374.8K$21M+0.11%
Q1 202369.2K$19M+0.11%
Q4 202266.2K$18M+0.12%
Q3 202278.4K$21M+0.14%
Q2 202280.0K$16M+0.11%
Q1 202242.3K$9M+0.05%
Q4 202165.7K$16M+0.08%
Q3 202187.6K$25M+0.13%
Q2 202196.3K$33M+0.17%
Q1 202187.2K$24M+0.14%
Q4 202061.7K$15M+0.09%
Q3 202064.4K$18M+0.13%
Q2 2020130.4K$35M+0.15%
Q1 202039.4K$12M+0.27%
Q4 201943.9K$13M+0.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of BIIB.